NPC

Clinical trials for NPC explained in plain language.

Never miss a new study

Get alerted when new NPC trials appear

Sign up with your email to follow new studies for NPC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1 Not yet finished but already full! 1

New combo therapy shows promise for advanced nose cancer

Disease control Ongoing

This study tested a new treatment for people with stage IVA nasopharyngeal cancer, a type of nose and throat cancer. The treatment combined the immunotherapy drug pembrolizumab with chemotherapy and radiation, followed by maintenance pembrolizumab for a year. The goal was to see …

Matched conditions: NPC

Phase: PHASE2 • Sponsor: Chinese University of Hong Kong • Aim: Disease control

Last updated May 11, 2026 20:49 UTC

NPC

Get alerted when new NPC trials appear

New combo therapy shows promise for advanced nose cancer